Literature DB >> 11298175

Midazolam reduces the dose of propofol required for induction of anaesthesia and laryngeal mask airway insertion.

P S Gill1, J Shah, A Ogilvy.   

Abstract

BACKGROUND AND
OBJECTIVE: Insertion of the laryngeal mask airway in the anaesthetized patient can sometimes be difficult and propofol has been advocated as the anaesthetic induction agent of choice because of its depressant effect on laryngeal reflexes compared with other intravenous anaesthetics. However, when used as the sole induction agent, relatively large doses of propofol are required to achieve successful laryngeal mask insertion. This has cost implications and may produce unwanted cardiorespiratory depression.
METHODS: One hundred and forty-two patients were randomized to receive either: fentanyl 1 microg kg(-1) and lidocaine 1.5 mg kg(-1) (group 1), or fentanyl 1 microg kg(-1) and midazolam 0.04 mg kg(-1) (group 2), or fentanyl 1 microg kg(-1), midazolam 0.04 mg kg(-1) and lidocaine 1.5 mg kg(-1) (group 3) or fentanyl 1 microg kg(-1) (group 4) 2 min before induction of anaesthesia. Anaesthesia was established with propofol infused at 33.3 mg min(-1).
RESULTS: Patients who were given midazolam required significantly less propofol to achieve satisfactory laryngeal mask insertion, median propofol doses: group 1, 1.63 mg kg(-1); group 2, 1.16 mg kg(-1); group 3, 1.01 mg kg(-1); group 4, 1.9 mg kg(-1), P < 0.0001 (analysis of variance). Patients given midazolam reported less pain on injection with propofol 13% and 3% groups (2 and 3) compared with 37.5% and 77% (groups 1 and 4) P = 0.002 (chi(2)).
CONCLUSIONS: Midazolam reduces the dose of propofol required for induction of anaesthesia and successful insertion of the laryngeal mask airway. There was no clinical benefit to be gained from the addition of lidocaine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11298175     DOI: 10.1046/j.0265-0215.2000.00805.x

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  6 in total

1.  Effect-site concentration of propofol required for LMA-Supreme™ insertion with and without remifentanil: a randomized controlled trial.

Authors:  Matilde Zaballos; Emilia Bastida; Salomé Agustí; Maite Portas; Consuelo Jiménez; Maite López-Gil
Journal:  BMC Anesthesiol       Date:  2015-10-06       Impact factor: 2.217

2.  Propofol for laryngeal mask airway insertion in children: Effect of two different doses.

Authors:  Mahin Seyedhejazi; Mahmoud Eydi; Morteza Ghojazadeh; Aref Nejati; Kamyar Ghabili; Samad Ej Golzari; Afshin Iranpour
Journal:  Saudi J Anaesth       Date:  2013-07

Review 3.  Airway reactions and emergence times in general laryngeal mask airway anaesthesia: a meta-analysis.

Authors:  Ana Stevanovic; Rolf Rossaint; Harald G Fritz; Gebhard Froeba; Joern Heine; Friedrich K Puehringer; Peter H Tonner; Mark Coburn
Journal:  Eur J Anaesthesiol       Date:  2015-02       Impact factor: 4.330

4.  JM-1232(-) and propofol, a new combination of hypnotics with short-acting and non-cumulative preferable properties.

Authors:  Saori Taharabaru; Takahiro Tamura; Michiko Higashi; Naoyuki Matsuda; Maiko Satomoto; Yushi U Adachi; Aiji Boku Sato; Masahiro Okuda
Journal:  Exp Anim       Date:  2020-10-16

5.  Combined sedation with midazolam/propofol for gastrointestinal endoscopy in elderly patients.

Authors:  Astrid Kerker; Christian Hardt; Hans-Eugen Schlief; Franz Ludwig Dumoulin
Journal:  BMC Gastroenterol       Date:  2010-01-27       Impact factor: 3.067

6.  Dexmedetomidine with propofol versus fentanyl with propofol for insertion of Proseal laryngeal mask airway: A randomized, double-blinded clinical trial.

Authors:  Jaya Choudhary; Aaditya Prabhudesai; Chumki Datta
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2019 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.